TrueLok Elevate transverse bone transport for lower‑limb ulcers
Official title: Post-Market Clinical Follow-up Study of the TrueLok Elevate Transverse Bone Transport System for the Treatment of Lower Limb Ulcers as Soft Tissue Defects
Run by Orthofix s.r.l. · NCT07079774 · Data updated 2026-11-12
This project tests the TrueLok Elevate device in adults with chronic lower‑limb ulcers to see if controlled bone cuts and gradual distraction improve local blood flow and help wounds heal.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 153 (estimated) |
| Sponsor | Orthofix s.r.l. Industry-sponsored |
| Locations | 14 sites (Halle and 13 other locations) |
| Status | Recruiting |
| Started | November 24, 2025 |
| Main results expected | November 24, 2028 |
| Study ends | November 24, 2028 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT07079774 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with chronic lower‑limb ulcers present ≥3 months that have failed standard non‑surgical or surgical wound treatments and who are indicated for transverse bone transport surgery are the ideal candidates.
✕Probably not a fit
Patients who cannot adhere to postoperative care or follow‑up due to cognitive, behavioural, or other medical limitations, or those who respond to standard wound care or are not surgical candidates, are unlikely to benefit from this device.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, multicenter registry of the TrueLok Elevate Transverse Bone Transport System used during indicated surgical care for adults with bony or soft‑tissue defects and chronic lower‑limb ulcers. The device uses a controlled corticotomy and slow transverse distraction to stimulate local vascularization and promote wound healing while patients receive standard postoperative follow‑up. Eligible patients have ulcers present for at least three months that have not responded to standard non‑surgical or surgical wound care. Data will be collected on wound healing, limb salvage, device performance, and safety across participating centers in Europe and South Africa.
Why it matters
Potential benefit: If successful, this approach could improve local blood flow and help stubborn lower‑limb ulcers close, potentially reducing the need for further surgery or amputation.
How similar studies have gone: Case series and small observational reports of transverse bone transport (including tibial transports) have reported improved wound healing and limb salvage in refractory lower‑limb ulcers, but randomized controlled data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Aged 18 years or older at the time of surgery Willing and able to sign and date the study-specific informed consent form in accordance with national and institutional ethics requirements Willing and able to comply with requirements of the protocol, including follow-up requirements Indicated for surgical intervention using the TrueLok Elevate Transverse Bone Transport System for the treatment of soft tissue defects in the form of lower limb ulcers Presence of a chronic ulcer, defined as: * Present for at least 3 months, and * Unresponsive to standard non-surgical or surgical wound management, including but not limited to debridement, negative pressure wound therapy (VAC), offloading, antibiotics, or vascular optimisation Exclusion Criteria: Mental or cognitive impairment or physiological or behavioural conditions that, in the opinion of the investigator, would preclude reliable adherence to postoperative care instructions, follow-up assessments, or study procedures Known or presenting with the following signs of a systemic inflammatory response syndrome (SIRS) as exhibiting two or more of the following conditions: o * Heart rate \>90 beats/min * Respiratory rate \>20 breaths/min * PaCO2 \<32-mm Hg * White blood cell count \>12.000 or \<4.000/cu mm * 10% immature (band) forms Known hypersensitivity or allergy to any material used in the TrueLok Elevate Transverse Bone Transport System (e.g., stainless steel, titanium) Current participation in another interventional clinical study that, in the opinion of the investigator, may interfere with the objectives or outcomes of this study Presence of active malignancy or systemic infection that, in the investigator's opinion, may interfere with wound healing or the study protocol Life expectancy of less than 12 months Simultaneous bilateral application of the TrueLok Elevate Transverse Bone Transport System Current incarceration at the time of enrolment Any condition or clinical circumstance that, in the opinion of the investigator, would make participation not in the best interest of the subject or would interfere with the study objectives
Where it's running
-
Helios Klinikum Wuppertal GmbH
Wuppertal, Germany Recruiting -
Stellenbosch University
Cape Town, Western Cape, South Africa Recruiting -
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain Recruiting -
Hospital Universitario Parc Taulí
Barcelona, Spain Recruiting -
Hull University Teaching Hospitals NHS Trust
Hull, United Kingdom Recruiting -
Universitätsklinikum Halle
Halle, Germany Not yet recruiting
Show 8 more locations
-
Krankenhaus GmbH Landkreis Weilheim-Schongau
Weilheim, Germany Not yet recruiting -
General Regional Hospital F. Miulli of Acquaviva delle Fonti
Acquaviva delle Fonti, Bari, Italy Active not recruiting -
Azienda Ospedaliero Universitaria di Parma
Parma, Pr, Italy Not yet recruiting -
Sant'Andrea Hospital - University of Rome "La Sapienza"
Roma, Rm, Italy Active not recruiting -
San Giovanni Evangelista Hospital
Tivoli, Rm, Italy Not yet recruiting -
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Palermo, Italy Not yet recruiting -
Fakultná nemocnica s poliklinikou Žilina
Žilina, Slovakia Not yet recruiting -
Newcastle's Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom Active not recruiting
Study contacts
- Study coordinator: Jay Erturan, MD
- Email: jerturan@orthofix.co.uk
- Phone: 7779 32 32 44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PowerHeal Bioelectric Bandage for infected open wound recovery
This tests whether the PowerHeal™ Bioelectric Bandage helps adults with infected traumatic wounds heal faster and clear infection better than standard dressings.
-
Buccal fat pad versus palatal rotation scarf graft for soft tissue around zygomatic implants
We will test two grafting techniques—the buccal fat pad and the palatal rotation scarf—to see which better builds and stabilizes gum tissue around zygomatic implants in adults with severely atrophic upper jaws.
-
Using hypnosis to reduce pain during stitches in the emergency room
This study is testing whether using hypnosis can help reduce pain and stress for people getting stitches in the emergency room.
-
4-aminopyridine for faster skin wound healing
This trial will see if 4-aminopyridine helps small skin wounds heal faster in healthy adults aged 18–70.
-
Tracking the healing of chronic venous leg ulcers with a special foam dressing
This study is testing a special foam dressing to see if it helps people with chronic venous leg ulcers heal better over six weeks.
-
Tracking the healing of chronic wounds with a special dressing
This study is testing a special dressing called Mepilex Up to see if it helps people with chronic wounds, like venous leg ulcers and diabetic foot ulcers, heal better over six weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.